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(calcium-signal modulating cyclophilin ligand), and Cyp40
is part of the Hsp90/Hsc70 complex that binds steroid
receptors. Likewise, FKBP12 is a subunit of two calcium
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is needed for the function of the MDR drug efflux pumpLa Jolla, California 92037-1099
in yeast, and interacts with type 1 TGFb receptors. This
diverse collection of targets suggests that PPIases play
a role in a wide variety of cellular processes. Despite
their lack of structural similarity, the cyclophilins andThe activity of transcription factors in eukaryotic cells
FKBPs do have a common property, namely that theycan be controlled by posttranslational modification, in-
interact stably with the calcium-regulated protein phos-teraction with inhibitory proteins, and cytoplasmic se-
phatase, known as calcineurin or PP2B, when bound toquestration. In this regard a number of different types
CsA and FK506 respectively. Indeed, it is the sequestra-of enzyme are known to regulate transcription factor
tion and inhibition of calcineurin in lymphocytes thatfunction. For instance, phosphorylation and dephos-
prevents these cells from responding to antigen-inducedphorylation by protein kinases and phosphatases are
mitogenic signals, thus resulting in immunosuppression.well-established mechanisms for modulating transcrip-
Despite the evidence that cyclophilins and FKBPstion factor activity. Protein-lysine acetylases are the lat-
have specific physiological targets, genetic analysis ofest newcomers to the catalog of enzymes that can
PPIase function in budding yeast has yielded a surpris-regulate transcription factors through posttranslational
ing result. All the known members of the cyclophilin andmodification. A recent paper in the January issue of
FKBP families can be disrupted, and the cells surviveMolecular Cell (Leverson and Ness, 1998) now adds
although they grow slowly (Dolinski et al., 1997a). The
another possible mechanism of enzymatic regulation to
only essential PPIase in yeast is Ess1p, which is the
the list. Leverson and Ness report that the DNA-binding
homolog of the mammalian parvulin family PPIase Pin1.
activity of the c-Myb transcription factor is negatively Cells depleted of Ess1p arrest in mitosis, whereas over-
regulated by a stable interaction with Cyp40, a member expression of Pin1 delays HeLa cells in G2, consistent
of the cyclophilin family of peptidyl-prolyl isomerases. with a role for Ess1p/Pin1 in progression into and
Peptidyl-Prolyl Isomerases through M phase (Lu et al., 1996). Interestingly, the
There are three families of peptidyl-prolyl isomerases Drosophila homolog of Ess1p, Dodo, is not essential
(PPIase): the cyclophilins, which bind the immunosup- (Maleszka et al., 1996).
pressant cyclosporin A (CsA), the FK506-binding pro-
teins (FKBPs), which bind the immunosuppressant
FK506, and the parvulin family (for review, see Dolinski
and Heitman, 1997). The three PPIase families are unre-
lated in primary sequence and three-dimensional struc-
ture, and yet they all carry out the same reaction, namely
the cis-trans isomerization of the peptide bond on the
N-terminal side of proline residues in proteins. In bud-
ding yeast there are eight cyclophilin family genes
(CPR1±8) and four FKBP genes (FPR1±4); in mammals
at least five cyclophilins (CypA±D,Cyp40) and six FKBPs
(FKBP12, 12.6, 13, 25, 52, 54) are known. In contrast,
eukaryotes have one or at most two parvulin family
PPIases.
Although cis-trans isomerization of prolyl-peptide
bonds occurs spontaneously, acceleration of this pro-
cess by PPIases could play a role in protein folding or
refolding by catalyzing a rate-limiting step (for review,
see Schmid, 1995). PPIases may also be involved in
assembly/disassembly of protein complexes, protein
trafficking, and direct regulation of protein activity. Ini-
tially, it was thought that like chaperonins the PPIases
would be pleiotropic, but there is emerging evidence Figure 1. Regulation of c-Myb DNA-Binding Activity by Cyp40
that individual PPIases in thecyclophilin and FKBP fami- The three repeats of the N-terminal c-Myb DNA-binding domain are
linked to the transactivation domain (AD) and the C-terminal nega-lies have restricted substrate protein specificity. Indeed,
tive regulatory domain (NRD), which interacts with the DBD via thePPIase activity is known to be important in the function
EVES motif. The four mutations in the v-Myb DBD are indicated byof particular proteins. For instance, correct localization
short black bars. The N-terminal peptidyl-prolyl isomerase (PPIase)
of two of the rhodopsins in the Drosophila eye requires domain is shown as a Pacman linked to the C-terminal domain
the NinaA cyclophilin. In addition, CypA interacts specif- containing three tetratricopeptide (TPR) repeats (crosshatched
boxes). DNA is shown as a horizontal bar.ically with the HIV capsid protein, CypB binds CAML
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The selection of specific prolyl peptide bonds in natu- motif, increases the transcriptional activity of c-Myb
from the CD34 but not the mim-1 promoter suggestingral protein substrates is likely to involve interactions of
the PPIases with additional residues lying on either side that phosphorylation of Ser528 negatively regulates
c-Myb activity (Miglarese et al., 1996). Intriguingly, p100,of the Pro and perhaps elsewhere in the protein (Gamble
et al., 1996). In addition, each PPIase family displays a a conserved transcriptional coactivator containing a
Myb-related EVES motif, interacts via its EVES motif withdifferent specificity for the residue preceding the Pro:
the FKBPs prefer a Pro preceded by a bulky hydropho- the c-Myb DBD and decreases c-Myb transcriptional
activity on a mim-1 reporter (Dash et al., 1996). Possibly,bic residue, whereas the cyclophilins show little prefer-
ence at this position. Parvulin, like the FKBPs, prefers phosphorylation of Ser528 increases p100 to c-Myb
binding by dissociating the EVES domain from the DBD.a hydrophobic residue at the 21 position (Rahfeld et al.,
1994), but the Pin1/Ess1p subfamily of parvulin PPIases v-Myb was derived from c-Myb through the loss of
N-terminal sequences including part of the first of thehave three conserved basic residues that form an anion
binding patch in the active site, which results in Pin1/ three repeats in the DBD, and the deletion of the C-termi-
nal NRD leaving the AD intact (Figure 1). In addition to theEss1p having a unique specificity for a phosphorylated
Ser or Thr preceding the Pro (Ranganathan et al., 1997; terminal truncations, v-Myb harbors 11 point mutations,
four of which are located in the DBD. None of theseYaffe et al., 1997). Indeed, Pin1 binds stably to a set of
mitotic phosphoproteins, comprising many of the anti- point mutations is essential for v-Myb myeloblast trans-
forming activity, but mutations in the DBD and AD aregens recognized by the MPM2 monoclonal antibody
(Crenshaw et al., 1998; Shen et al., 1998). Using a degen- required for monoblast transformation. Moreover, v-Myb
can activate expression of genes, such as Gbx2, whicherate phospho-Ser-containing phosphopeptide library,
a consensus for Pin1 binding has been deduced as are not activated by c-Myb alone, and this altered speci-
ficity may be important for monoblast transformation[WYF][FI][YRFW]pSP[RFYW][LI]. A catalytic rate en-
hancement of 3000-fold is observed with a consensus (Kowenz-Leutz et al., 1997).
The fact that c-Myb is negatively regulated by intramo-phosphopeptide substrate compared to the unphos-
phorylated form, underscoring the importance of the lecular association between the DBD and the NRD sug-
gested that c-Myb could be activated by an enzymephosphate (Yaffe et al., 1997). The majority of the
cyclophilins and FKBPs are cytoplasmic proteins, al- known to modify protein conformation. For this reason,
Leverson and Ness (1998) examined the interaction be-though CypA, Cyp40, FKBP25, and FKBP52 may have
dual nuclear and cytoplasmic localization (Dolinski and tween a cyclophilin family PPIase and c-Myb. They
showed that c-Myb binds to Cyp40 in vitro, throughHeitman, 1997). Pin1 is localized in the nucleus (Lu et
al., 1996), but it is not known whether other members interaction between the C-terminal tetratricopeptide
(TPR) repeat domain of Cyp40 and the DBD of c-Myb.of the parvulin family are nuclear proteins.
Myb Family Transcription Factors Addition of recombinant Cyp40 to a nuclear extract of
Jurkat cells abolishes c-Myb DNA-binding activity de-c-Myb was originally identified as the protooncogene
that engendered the v-Myb oncogene of avian myelo- tected by a gel shift assay. This effect is reversed by
CsA, which binds to and inactivates the N-terminal PPI-blastosis virus, which induces a myeloblastic leukemia
in chickens. c-Myb is a highly conserved 75±89 kDa ase domain of Cyp40. In contrast, Cyp40 does not bind
to v-Myb, nor does it inhibit its DNA-binding activitytranscription factor, which is essential for normal fetal
hepatic hematopoiesis, but not for yolk sac hematopoie- when added to a nuclear extract from AMV-transformed
BM2 myeloblast cells. The failure of Cyp40 to bind tosis in the mouse (for review, see Ness, 1996). The precise
function of c-Myb in hematopoiesis is not clear, but it v-Myb is presumably accounted for by one or more of
the point mutations in the v-Myb DBD. Interestingly,is presumed to involve regulation of genes involved in
myeloid lineage commitment. c-Myb has three func- three of the altered residues map to a small region on
the surface of the DBD (Ogata et al., 1994), which pre-tional domains, an N-terminal DNA-binding domain
(DBD, residues 38±192), a central acidic transactivation sumably provides part of the binding site for Cyp40.
Leverson and Ness conclude that Cyp40 plays a role indomain (AD, residues 240±365), and a C-terminal nega-
tive regulatory domain (NRD, residues 400±570), which negative regulation of c-Myb function through its PPIase
activity, and that the mutations in the v-Myb DNA-bind-includes a leucine zipper (Figure 1). c-Myb is the proto-
type for a large family of transcription factors with re- ing domain were selected to eliminate this negative reg-
ulation (Figure 1). Indeed, the fact that the mutations inlated DNA-binding domains that contain two or three
repeats each with a three-helix fold similar to that of the v-Myb DNA-binding domain prevent Cyp40 binding
provides strong support for the physiological relevancethe homeodomain. A consensus DNA-binding sequence
(PyAACG/TG) has been established for the Myb DBD, of the interaction of c-Myb with Cyp40. Mutations in
oncoproteins that vitiate negative regulation are a com-and a number of genes that are targets for Myb activa-
tion (e.g., mim-1 and CD34) or repression (e.g., c-fms) mon principle of oncogenic activation (e.g., the loss of
the C-terminal regulatory Tyr in c-Src), and the pointhave been identified. NRD residues 513±563, a con-
served region that includes the EVES motif, interact with mutations in the Myb DBD provide another example.
The finding that Cyp40 negatively regulates the DNA-the DBD (Dash et al., 1996). c-Myb function is negatively
regulated by this interaction. In principle, this could be binding activity of c-Myb in vitro raises a number of
questions. Foremost is whether Cyp40 regulates c-Mybbecause the NRD±DBD interaction decreases DNA-
binding activity, but this has not been rigorously tested. transcriptional activity in the cell. Does c-Myb associate
with Cyp40 in vivo? Does overexpression of Cyp40 de-Mutation of Ser528 in mouse c-Myb, which is a MAP
kinase site and corresponds to the Ser in the EVES crease c-Myb transcriptional activation activity? Does
Minireview
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CsA increase c-Myb transcriptional activity using a re- in mind that it has not been unequivocally established
that Pin1's cell cycle function requires it to act as aporter gene assay? Do other cyclophilins or FKBPs (e.g.,
PPIase as opposed to simply binding to its phosphory-FKBP52 which also has TPR repeats) interact with
lated targets. This is an important issue, because par-c-Myb? Although CsA, an inhibitor of Cyp40 PPIase ac-
vulin has much lower activity in protein folding assaystivity, prevents Cyp40 from inhibiting c-Myb DNA bind-
than on peptide substrates (Scholz et al., 1997a). Theing without blocking its binding to c-Myb, it is not strictly
currently ascribed function of Pin1 is at the G2/M transi-clear that Cyp40 PPIase activity is required to inhibit
tion, but in principle it could also recognize substratesc-Myb DNA binding, since bound CsA might preclude
for other proline-directed protein kinases, such as MAPa PPIase-independent interaction of the Cyp40 PPIase
kinases, and thus have cell cycle independent functions.domain with the DBD. Ideally, a PPIase-deficient Cyp40
The fact that none of the yeast cyclophilins or FKBPsmutant should be tested in this system, but not all muta-
are essential implies that these PPIases do not havetions that inactivate cyclophilins and FKBPPPIase activ-
a critical nuclear function. However, although buddingity on peptide substrates abolish activity against protein
yeast has no additional PPIases of these types, theresubstrates (Dolinski et al., 1997b; Scholz et al., 1997b).
could be other novel types of PPIase. Nuclear functionThere is also the issue of whether Cyp40 has to associ-
is increasingly recognized to involve the assembly andate stoichiometrically with c-Myb or whether it acts cata-
disassembly of macromolecular complexes, and theselytically to decrease DNA binding. Is there a target Pro
would make attractive targets for PPIases that couldnear the region mapped out on the surface of the DBD
regulate protein±protein interactions through conforma-by the v-Myb mutations, or does the target peptide bond
tional changes.lie elsewhere in c-Myb, for instance in the hinge region in
the AD, which contains a number of conserved prolines?
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